Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

A full service Thai brokerage

Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

Equity Bottom-Up

<ul><li>1Q26 net profit beat market expectations, driven by stronger-than-expected revenue growth and margin improvement, reflecting a turning point in the recovery of complex disease treatments following last year’s slowdown caused by fewer bariatric surgery cases.</li><li>CHG reported 1Q26 net profit came in at Bt248mn (+10% YoY, +10% QoQ), beating market expectations for a YoY and QoQ decline, driven by stronger-than-expected revenue growth and a better-than-expected gross profit margin (GPM).</li><li>GPM improved to 28.6% (vs. 27.6% in 1Q25), reflecting a higher proportion of complex disease treatments, which more than offset the negative impact from a 44 bps increase in SG&amp;A to sales due to higher salaries and commissions.</li></ul>

1Q26 net profit beat market expectations, driven by stronger-than-expected revenue growth and margin improvement, reflecting a turning point in the recovery of complex disease treatments following last year’s slowdown caused by fewer bariatric surgery cases.CHG reported 1Q26 net profit came in at Bt248mn (+10% YoY, +10% QoQ), beating market expectations for a YoY and QoQ decline, driven by stronger-than-expected revenue growth and a better-than-expected gross profit margin (GPM).GPM improved to 28.6% (vs. 27.6% in 1Q25), reflecting a higher proportion of complex disease treatments, which more than offset the negative impact from a 44 bps increase in SG&amp;A to sales due to higher salaries and commissions.

출라랏 병원(CHG): 2026년 1분기 실적, 마진 회복에 힘입어 예상치 상회

Chularat Hospital

출라랏 병원(CHG): 2026년 1분기 실적, 마진 회복에 힘입어 예상치 상회